James R. Largent
Keine laufenden Positionen mehr
Vermögen: 50 700 $ am 31.03.2024
Profil
James R.
Largent served as Vice President of Strategic Planning at Allergan, Inc. from 1996 to 2002.
He was a Director at BIOLASE, Inc. from 2007 to 2010, TearScience, Inc. from 2007 to 2016, and SOLX, Inc. He was also Secretary at World Am, Inc. from 2005 to 2008.
Largent served as Lead Independent Director at Alimera Sciences, Inc. from 2019 to 2023.
He holds an MBA and an undergraduate degree from the University of California, Irvine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ALIMERA SCIENCES, INC.
0,02% | 04.01.2023 | 13 000 ( 0,02% ) | 50 700 $ | 31.03.2024 |
Ehemalige bekannte Positionen von James R. Largent
| Unternehmen | Position | Ende |
|---|---|---|
| ALIMERA SCIENCES, INC. | Chairman | 02.01.2019 |
TearScience, Inc.
 TearScience, Inc. Electronic ComponentsElectronic Technology TearScience, Inc. diagnoses and treats meibomian gland dysfunction. It offers Lipiflow, Lipiscan, and Lipiview. The company was founded by Donald R. Korb and Timothy R. Willis in 2005 and is headquartered in Morrisville, NC. | Director/Board Member | 01.01.2016 |
| BIOLASE, INC. | Director/Board Member | 26.08.2010 |
| WORLD AM, INC. | Corporate Secretary | 01.12.2008 |
| ALLERGAN, INC. | Corporate Officer/Principal | 01.02.2002 |
Ausbildung von James R. Largent
| University of California, Irvine | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| BIOLASE, INC. | Health Technology |
| WORLD AM, INC. | Electronic Technology |
| ALIMERA SCIENCES, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
TearScience, Inc.
TearScience, Inc. Electronic ComponentsElectronic Technology TearScience, Inc. diagnoses and treats meibomian gland dysfunction. It offers Lipiflow, Lipiscan, and Lipiview. The company was founded by Donald R. Korb and Timothy R. Willis in 2005 and is headquartered in Morrisville, NC. | Electronic Technology |
SOLX, Inc.
 SOLX, Inc. Medical SpecialtiesHealth Technology SOLX, Inc. specializes in management and surgical treatment of glaucoma. It offers Gold Shunt is a novel, minimally invasive device that advances the surgical treatment of glaucoma. The company was founded by Doug P. Adams in 2000 and is headquartered in Waltham, MA. | Health Technology |
| Allergan Medical Optics |
